Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Maria Angeles Lopez-Olivo"'
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 2 (2023)
Background Immune checkpoint inhibitors (ICI) can cause off-target inflammatory and immune-related adverse events (irAE). Conceivably, COVID-19 vaccination could trigger an inflammatory and immune response that could induce or aggravate irAE.Methods
Externí odkaz:
https://doaj.org/article/9039d937afb34dfa9b1f1a541cef0575
Autor:
Jasvinder A. Singh, Robin Christensen, George A. Wells, Maria E. Suarez-Almazor, Rachelle Buchbinder, Maria Angeles Lopez-Olivo, Elizabeth Tanjong Ghogomu, Peter Tugwell
Publikováno v:
São Paulo Medical Journal, Vol 128, Iss 5, Pp 309-310
Externí odkaz:
https://doaj.org/article/0e2e230febce43549a94f2b265ada4f6
Autor:
Sebastian Bruera, Harish Sidanmat, Donald A Molony, Maureen D Mayes, Maria E Suarez-Almazor, Kate Krause, Maria Angeles Lopez-Olivo
Publikováno v:
Cochrane Database of Systematic Reviews. 2022
Systemic sclerosis (SSc) is a chronic autoimmune disease characterized by systemic inflammation, fibrosis, vascular injury, reduced quality of life, and limited treatment options. Autologous hematopoietic stem cell transplantation (HSCT) has emerged
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee6d10eb845792065aa9344485cef516
https://doi.org/10.1002/14651858.cd011819.pub2
https://doi.org/10.1002/14651858.cd011819.pub2
Autor:
Stephanie Frade, Melainie Cameron, Gisela Espinosa-Cuervo, Maria E Suarez-Almazor, Maria Angeles Lopez-Olivo
Publikováno v:
Cochrane Database Syst Rev
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the efficacy and safety of exercise and physical therapies in people with systemic sclerosis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9537b864a5ea704ee1022ff31c9f1af
https://doi.org/10.1002/14651858.cd014902
https://doi.org/10.1002/14651858.cd014902
Publikováno v:
Journal for ImmunoTherapy of Cancer. 11:e006246
BackgroundImmune checkpoint inhibitors (ICI) can cause off-target inflammatory and immune-related adverse events (irAE). Conceivably, COVID-19 vaccination could trigger an inflammatory and immune response that could induce or aggravate irAE.MethodsTh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff3f30187ef9feca921cda4c0f05065e
https://doi.org/10.1136/jitc-2022-006246
https://doi.org/10.1136/jitc-2022-006246
Publikováno v:
The Cochrane database of systematic reviews. (7)
Tocilizumab, a new biologic that inhibits interleukin-6, is approved for treatment of rheumatoid arthritis (RA) in Europe, Japan and the US.To assess the efficacy and safety of tocilizumab in patients with RA using the data from published randomized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::863aab17b2955f858fd51117aa0e5dd4
https://pubmed.ncbi.nlm.nih.gov/20614469
https://pubmed.ncbi.nlm.nih.gov/20614469